MPN experts Dr. Mark Heaney of Columbia University Cancer Center and Dr. Srdan Verstovek of MD Anderson Cancer Center examine the expanding polycythemia vera (PV) armamentarium, answering the question, “Where are we now?” Dr. Heaney discusses second generation inhibitors and customization of treatment, while Dr. Verstovek focuses on combination therapies and expanded options coming from interferon trials in Europe.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Advertisement